Hongshan Guo

Wuhan University of Technology — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index8.7kcitations74works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(23), Ferroptosis and cancer prognosis(22), Cancer, Lipids, and Metabolism(22), Epigenetics and DNA Methylation(18), Cancer-related molecular mechanisms research(14)

Publications74 total

CDK12 Deficiency Induces BRD4S to Promote Cancer Metastasis by Enhancing Phase Separation and Chromatin Engagement
Cancer Research·2025
Recent advances of CRISPR screen in cancer immunology
Chinese Science Bulletin (Chinese Version)·2025
RNA m6A modification: a key regulator in normal and malignant processes
Cell investigation.·2025· 8 citedOpen Access
Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer
Scientific Reports·2025· 2 citedOpen Access
Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer
2025Open Access
Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice
Nature Communications·2025· 21 citedOpen Access
Spatial Total RNA Sequencing of Formalin-Fixed Paraffin Embedded Tissues by spRandom-seq
2025Open Access
The Impact of the Belt and Road Initiative on Changes in Trade Volume in Countries Along the Route: A Study Based on the Mann-Kendall Test and STL Decomposition
Advances in economics, business and management research/Advances in Economics, Business and Management Research·2025Open Access
SLC7A5: A Potential Molecular Target for the Diagnosis and Treatment of TNBC
BIO Web of Conferences·2025Open Access
Prognostic Potential of AKR1B1 in triple-negative breast cancer
BIO Web of Conferences·2025Open Access
Advances and applications in single-cell and spatial genomics
Science China Life Sciences·2024· 46 cited
Abstract IA005: Tumor cell-based liquid biopsy to characterize prostate cancer
Clinical Cancer Research·2024
The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia
Blood·2024· 2 cited
LncRNA GUSBP11/miR-28-5p/PAQR7 axis regulates the phosphorylation of E-cadherin and N-cadherin on the migration of papillary thyroid carcinoma cells
2024Open Access
De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data
Genome Medicine·2023· 11 citedOpen Access
DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs
Cell·2023· 65 citedOpen Access
Table S3 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
2023Open Access
Table S2 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
2023Open Access
Table S8 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
2023Open Access
Table S6 from The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Fuchou Tang(22), Lu Wen(17), Xinglong Wu(15), Shyamala Maheswaran(15), Daniel A. Haber(13), Liying Yan(12), Jie Qiao(12), Ben S. Wittner(12), Mehmet Toner(11), Ping Zhu(10), Boqiang Hu(10), Taronish D. Dubash(10), Linda T. Nieman(10), Jie Yan(9), Jun Yong(9), Risa Burr(9), Fan Guo(8), Xiaoying Fan(8), Xin Hong(8), Benjamin Wesley(8)